Related Experiment Video
Updated: May 3, 2026

07:11
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
7.7K
Glucose-induced temporary visual recovery in primary open-angle glaucoma: a double-blind, randomized study.
Robert J Casson1, Guoge Han1, Andreas Ebneter1
1South Australian Institute of Ophthalmology, University of Adelaide, Adelaide, South Australia.
Ophthalmology
|February 5, 2014
Summary
Topical glucose eye drops improved contrast sensitivity in patients with primary open-angle glaucoma (POAG). This suggests glucose may help restore function in damaged retinal neurons for better vision.
Area of Science:
- Ophthalmology
- Neuroscience
Background:
- Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness.
- Understanding factors that influence visual function in POAG is crucial for developing new treatments.
Purpose of the Study:
- To evaluate the impact of topical glucose on visual parameters in individuals diagnosed with POAG.
- To explore glucose's potential as a therapeutic agent for visual dysfunction in glaucoma.
Main Methods:
- A double-blind, randomized, crossover study design was employed.
- Participants received either 50% glucose or saline eye drops.
- Contrast sensitivity and visual acuity (logMAR) were measured as primary outcomes.
Main Results:
- Topical 50% glucose significantly enhanced contrast sensitivity at 12 cycles/degree in pseudophakic POAG patients.
- Glucose reached the vitreous in pseudophakic eyes but not phakic eyes.
- No significant effects were observed on intraocular pressure, refraction, or corneal thickness.
Conclusions:
- Topical glucose demonstrates a temporary improvement in visual function for some POAG patients.
- This suggests that enhancing neuronal energy substrate delivery may aid in recovering retinal neuron function.
- Further research into glucose's role in glaucoma management is warranted.
Related Concept Videos
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview
1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K

